NUCLEOLIN and cancer: In a recent paper, PAMAM-PEG-based dendrimers were conjugated to the anti-nucleolin aptamer and 5-fluorouracil (5-FU) chemotherapeutic drug, achieving 5-FU specific accumulation in target cancer cells [123].